AntiCoagulation Tracking InterVention and Evaluation: Using a Customized Panel Management Platform to Improve Outcomes for Patients on Anticoagulation
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 主要终点
- Time in Therapeutic Range
研究概览
简要总结
Anticoagulants are a leading cause of acute injury from adverse drug events, leading to ~20,000 serious injuries reported to the Food and Drug Administration per year and more than 220,000 emergency department visits annually. Therefore, we propose to implement a health information technology (HIT) population management tool at two distinct anticoagulation clinics that will allow the care team to assign and track tasks essential for timely patient monitoring. We will examine its effect on anticoagulation management outcomes through a randomized trial, hypothesizing that such interventions can be effective as well as cost-effective strategies to improve patient safety in the context of anticoagulation management services.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 99 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Adults (age ≥18 years)
- •those prescribed an anticoagulation medication at Zuckerberg San Francisco General Hospital or University of California, San Francisco Health
排除标准
- •Minors (age<18)
- •those not prescribed anticoagulation medication at ZSFG or UCSF Health
研究组 & 干预措施
Intervention Arm
This cohort of patients will receive panel management through a customize software that integrates with the electronic health record
干预措施: Panel Management for Anticoagulation Therapy (Other)
Control Arm
This cohort of patients will receive usual care
干预措施: Usual Care (Other)
结局指标
主要结局
Time in Therapeutic Range
时间窗: 6 months
Using the Rosendaal method, we will assess the proportion of the treatment duration that the patient's International Normalized Ratio is within the goal therapeutic range.
次要结局
- Proportion Time in Range(6 months)
- Time from initiation to therapeutic INR (TWTR)(Study Period (average of 2 years))
- Adverse events(Study Period (average of 2 years))
